Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser

Launched by LONDON VISION CLINIC · May 21, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how well a specific eye surgery called PTK-PRK works for people with myopia (nearsightedness) and astigmatism. The researchers want to see if the predictions made by a special software tool called EpiMaster about the results of this surgery match what actually happens to patients after they have the procedure. The goal is to gather real-life data to ensure patients receive the best possible care.

To participate in this trial, you should be between the ages of 76 and 70 and have myopia or both myopia and astigmatism. You'll need to understand the information provided about the trial and agree to follow-up visits for check-ups after your surgery. The trial is not yet recruiting, so there is no need to worry about signing up just yet. If you are eligible and choose to participate, you can expect to have your surgery done and then monitored to see how well your vision improves over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
• • Patient present with myopic or myopic and astigmatic error
• • Patient will be able to understand the patient information and willing to sign an informed consent
• • Patient will be willing to comply with all follow-up visits and the respective examinations
• Exclusion Criteria:
• • Exclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors